Rostec’s New Medical Solutions for 2023

Rostec’s New Medical Solutions for 2023

Participation in the government healthcare programs is one of the most important business tasks for Rostec. Over many years, the Corporation’s companies have produced high-technology medical equipment that is in high demand by medical facilities in Russia and former Soviet republics. Hundreds of clinics, hospitals and medical centers, including those built in partnership with Rostec, are furnished with advanced Russian lifesaving equipment. Nacimbio pharmaceutical holding is a vaccine supplier under the National Immunization Schedule. In addition, Rostec’s companies play an important role in the digitalization of medical services.

In 2023, the Corporation’s companies provided a number of new medical solutions that are already being used or will come into the market soon. The most interesting of them are described below.
 

Antigep-Neo immunoglobulin: no to virus!

Hepatitis B is still a socially significant and hazardous disease, especially for children. Besides vaccination, administration of specific immunoglobulins is used to prevent infection in infants and young children. One of such pharmaceutical products, Antigep-Neo, was approved by the Ministry of Health of the Russian Federation. The immunoglobulin has been developed and produced by NPO Microgen included in Nacimbio holding.

This drug used in addition to vaccination helps the child’s body acquire the specific immunity to the virus quicker. Compared with the previous generation pharmaceutical products, Antigen-Neo undergoes several additional purification stages to ensure high viral safety and minimize the risk of adverse reactions in patients. According to the manufacturer’s plans, the new drug will be available already in 2024.

 

Mobivent Oxy mechanical ventilator: especially for COVID patients

Many people became aware of mechanical ventilators for the first time during the COVID-19 pandemic. However, this equipment has been used in medical facilities long ago. Urals Instrument-Making Plant owned by Concern Radio-Electronic Technologies produced 15,000 mechanical ventilators during the pandemic period, thus, saving thousands of lives, and is focused on continuous improvement in this area.

Urals Instrument-Making Plant has completed the factory test of Mobivent Oxy, an advanced mechanical ventilator. It has been created especially for patients with COVID, chronic pulmonary and heart diseases and is designed for high-flow oxygen therapy in children and adults. This method is suitable only for patients capable of spontaneous inhale breathing. When used for treatment of infectious viral diseases with pulmonary complications, including coronavirus disease, this method improves the patient’s condition considerably. Mobivent Oxy will be the first product in the new mechanical ventilator family made by Rostec’s company based in Ural. Commercial production of the product is to be launched in 2024.

 

KardioRobot: to help intensivists

Manual closed-chest cardiac massage may be provided in a quality manner during emergency intensive care for maximum 2 to 3 minutes and this is often insufficient to start the “flaming motor”. And then human hands give way to a machine – automated KardioRobot designed by Research and Manufacturing Company Almaz as part of Ruselectronics holding. The device is available as a prototype so far, but there is already interest in it – according to the manufacturer’s estimate, Russian doctors need about 9,000 such machines.

The main objective of KardioRobot – is to increase the patient’s chances of survival and to relieve medical personnel for other important tasks. The device has an automatic chest compression function to support blood circulation during sudden cardiac arrest. KardioRobot can run on batteries continuously for 45 minutes. Owing to special sensors that measure blood pressure and blood oxygen level, the apparatus controls compression pressure and depth. The robot can be used both in hospitals and ambulances.

 

Personal Medical Assistants digital platform: online doctor

A new service has been launched this year as a pilot project in six Russian regions and allows doctors to receive online monitoring data from patients. United Instrument-Making Corporation is the operator of the Personal Medical Assistants digital platform, and the system is based on IoMT.Istok solution developed by RPC Istok named after Shokin using the concept of the industrial internet of things.

The platform provides remote health monitoring of patients with chronic diseases – arterial hypertension and diabetes. For this, the platform remotely collects measurements from personal medical devices and sends them to the information system of a medical facility for further processing by medical specialists. Using the data, doctors are able to adjust the treatment regimen in real time. It is planned to expand the types of monitoring and connected devices in future.